Results 171 to 180 of about 49,329 (202)
Some of the next articles are maybe not open access.
Scandinavian Journal of Clinical and Laboratory Investigation, 2011
CD163 is an endocytic receptor for haptoglobin-hemoglobin complexes and is expressed solely on macrophages and monocytes. As a result of ectodomain shedding, the extracellular portion of CD163 circulates in blood as a soluble protein (sCD163) at 0.7-3.9 mg/l in healthy individuals.
openaire +3 more sources
CD163 is an endocytic receptor for haptoglobin-hemoglobin complexes and is expressed solely on macrophages and monocytes. As a result of ectodomain shedding, the extracellular portion of CD163 circulates in blood as a soluble protein (sCD163) at 0.7-3.9 mg/l in healthy individuals.
openaire +3 more sources
CD163+ Macrophages Induce Endothelial-to-Mesenchymal Transition in Atheroma
Circulation ResearchBACKGROUND: Cell phenotype switching is increasingly being recognized in atherosclerosis. However, our understanding of the exact stimuli for such cellular transformations and their significance for human atherosclerosis is still evolving.
M. Mori +34 more
semanticscholar +1 more source
The significance of CD163-expressing macrophages in asthma
Annals of Allergy, Asthma & Immunology, 2019CD163 is one of the scavenger receptors that are specifically expressed on macrophages and are well known to be upregulated by various inflammatory responses, including chronic obstructive pulmonary disease in airway diseases.To evaluate the CD163 expression in the lungs of patients with fatal asthma and investigated whether CD163 contributes to the ...
Yoshihisa, Tokunaga +4 more
openaire +2 more sources
Mechanistic Insights into PRRSV Inhibition through CD163–SRCR5 Blockade by PRRSV/CD163-IN-1
The Journal of Physical Chemistry LettersPorcine reproductive and respiratory syndrome virus (PRRSV) causes severe economic losses in the swine industry by targeting pulmonary alveolar macrophages via the CD163 receptor, particularly its SRCR5 domain. However, the molecular details of small-molecule inhibition at this interface remain unclear.
Prawit Thitayanuwat +3 more
openaire +2 more sources
CD163 is not a sensitive marker for identification of atypical fibroxanthoma
Journal of Cutaneous Pathology, 2011The histopathological features of atypical fibroxanthoma (AFX) overlap with those of poorly differentiated carcinoma, melanoma and leiomyosarcoma in the skin. As there are no specific stains to identify AFX, the diagnosis is essentially one of exclusion and requires completion of a panel of immunostains.
openaire +2 more sources
CD163‐positive cancer cells are a predictor of a worse clinical course in lung adenocarcinoma
Pathology International, 2021Yoichi Saito +2 more
exaly
CD163+ and CD14+ macrophages are increased in obese children
Journal of Pediatric Endocrinology and Metabolism, 2023Nikita S. Denisov +6 more
openaire +2 more sources

